Log in to search using one of your social media accounts:

 

GlaxoSmithKline's Rockville chief lays out priorities for 2018
British pharmaceutical giant GlaxoSmithKline PLC said it finally has its full team in place at its vaccine hub in Rockville, ready to take on some of the region's most well-known biotech competitors with part of its product lineup. This next year, officials said, will be about taking a leadership position in new vaccine technologies and advancing its priority projects, including its vaccine for shingles as well its vaccine candidate for respiratory syncytial virus, a common respiratory virus that… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - December 8, 2017 Category: Health Management Authors: Tina Reed Source Type: news

SECOND OPINION | What's with all the studies on coffee, and why can't we get a straight answer?
Also: U.S.-style ads for a shingles vaccine are popping up in Canada — and they're perfectly legal. (Source: CBC | Health)
Source: CBC | Health - November 25, 2017 Category: Consumer Health News Tags: News/Health Source Type: news

Safety of Herpes Zoster Vaccine for IBD Patients on Anti-TNFs Safety of Herpes Zoster Vaccine for IBD Patients on Anti-TNFs
Is it safe to give herpes zoster vaccine while patients are on anti-TNF therapy?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 13, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

The New Old Age: No Excuses, People: Get the New Shingles Vaccine
Shingrix, which begins shipping this month, is far more effective than the previous shingles shot. Experts recommend it for everyone over age 50. (Source: NYT Health)
Source: NYT Health - November 10, 2017 Category: Consumer Health News Authors: PAULA SPAN Tags: Shingles (Disease) Vaccination and Immunization Elderly Drugs (Pharmaceuticals) Centers for Disease Control and Prevention GlaxoSmithKline PLC Source Type: news

Why Do We Need Separate Chicken-Pox And Shingles Vaccines?
The two diseases may arise from the same virus, but they afflict different populations and that is key. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - November 3, 2017 Category: Consumer Health News Source Type: news

White House opioid commission calls for wide-ranging changes to anti-drug policies
More drug courts and increased use of alternatives to opioids for people in pain may help curb the drug epidemic, commission saysRelated:Screams, torture and so much blood: The gruesome world of 19th-century surgeryShe signed up to be a surrogate mother — and unwittingly gave her own child awayWhat you need to know about the new shingles vaccine (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - November 1, 2017 Category: Consumer Health News Source Type: news

ACIP Recommends New Herpes Zoster Subunit Vaccine
The Advisory Committee on Immunization Practices is recommending preferential use of a new herpes zoster subunit (HZ/su; Shingrix) vaccine over currently available herpes zoster live (Zostavax) vaccine for adults ages 50 and older. (Source: AAFP News)
Source: AAFP News - October 31, 2017 Category: Primary Care Source Type: news

Screams, torture and so much blood: The gruesome world of 19th-century surgery
In these troubling times — amid melting glaciers, worries about a nuclear war and white supremacy rallies — it can sometimes be hard to appreciate our modern-day life. But here’s a thought guaranteed to make you feel grateful to be alive right now: Medical care in the Victorian era was a horrifying, gruesome affair. Just in […]Related:Toddler hospitalized after his father’s arrest postponed kidney donationShe signed up to be a surrogate mother — and unwittingly gave her own child awayWhat you need to know about the new shingles vaccine (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - October 31, 2017 Category: Consumer Health News Source Type: news

What you need to know about the new shingles vaccine
Barbara Campbell has twice had shingles. Each time, one side of her body was covered in “thousands of these horrid blisters.” She could only wear the lightest silk blouse. Anything else touching her skin hurt too much. “I’m in terror of having it happen again,” said Campbell, 79, of Fort Lauderdale, Fla., describing the painful […]Related:How the government can fight the opioid epidemic under a public health emergencyRise in mumps outbreaks prompts U.S. panel to endorse 3rd vaccine doseExpert panel recommends new shingles vaccine that gives increased protection (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - October 28, 2017 Category: Consumer Health News Source Type: news

Ask Well: Should I Get Revaccinated as an Adult?
Certain adults should be vaccinated against measles, mumps and whooping cough, diseases that are making a comeback. (Source: NYT Health)
Source: NYT Health - October 27, 2017 Category: Consumer Health News Authors: KAREN WEINTRAUB Tags: Whooping Cough Vaccination and Immunization Mumps Shingles (Disease) Tetanus Measles Source Type: news

Second University of Colorado vaccine approved by FDA for shingles
(University of Colorado Anschutz Medical Campus) The Centers for Disease Control's Advisory Committee on Immunization Practices recommended new treatment practices Wednesday for shingles based on a vaccine initially developed at the University of Colorado Health Sciences Center, now the University of Colorado Anschutz Medical Campus. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 27, 2017 Category: International Medicine & Public Health Source Type: news

Who should get the new shingles vaccine?
The FDA recently approved a new, more effective vaccine for the painful condition; do you need it? (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 26, 2017 Category: Consumer Health News Source Type: news

FDA Approves New Shingles Vaccine That Is More Than 90% Effective
BOSTON (CBS) – There’s a new shingles vaccine in town. Shingrix was approved by the FDA last week, and a CDC advisory panel just voted to recommend it for patients 50 and older. It is given as two injections two to six months apart, and in studies the vaccine was found to be more than 90% effective. Shingrix is not the only shingles vaccine available. Zostavax has been around for more than a decade, but it may not be as effective as this new vaccine, especially in older patients. Vaccine experts are not only recommending the new vaccine for people who have never been vaccinated but say that people who got the ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 26, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Syndicated Local Dr. Mallika Marshall Shingles Source Type: news

There's a New Shingles Vaccine -- Is It for You?
On the heels of approval of a better vaccine for the painful condition shingles, adults over 50 should plan to roll up their sleeves -- again. (Source: WebMD Health)
Source: WebMD Health - October 26, 2017 Category: Consumer Health News Source Type: news

Expert Panel Recommends New Shingles Vaccine, Shingrix, as First-Line Treatment
A new shingles vaccine that provides far more protection than its predecessor received the full blessing of a U.S. government vaccine advisory panel on Wednesday. In a close 8-7 vote, the Advisory Committee on Immunization Practices recommended... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 26, 2017 Category: General Medicine Source Type: news

There's a New Shingles Vaccine -- Is It for You?
Source: HealthDay Related MedlinePlus Pages: Immunization, Seniors' Health, Shingles (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - October 26, 2017 Category: Consumer Health News Source Type: news

How the government can fight the opioid epidemic under a public health emergency
According to the president, 175 people will die of overdoses today, and every day, until the epidemic is curbed. Related:Rise in mumps outbreaks prompts U.S. panel to endorse 3rd vaccine doseExpert panel recommends new shingles vaccine that gives increased protectionFDA’s Gottlieb calls for greater use of medication-assisted treatment to fight opioid epidemic (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - October 26, 2017 Category: Consumer Health News Source Type: news

There's a New Shingles Vaccine, Shingrix, -- Is It for You?
THURSDAY, Oct. 26, 2017 -- On the heels of approval of a better vaccine for the painful condition shingles, adults over 50 should plan to roll up their sleeves -- again. The new vaccine, Shingrix, will likely be recommended even for those already... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 26, 2017 Category: General Medicine Source Type: news

Pat yourself on the back, America. Your cholesterol levels are holding steady, CDC says.
When it comes to our health as a nation, we’re not doing so great. Some cancer rates are climbing sharply. Nearly one in eight Americans has diabetes. And we are ballooning in weight, with obesity rates at record highs. Amid that grim picture, government researchers on Thursday had a glimmer of good news: Our cholesterol numbers, […]Related:Rise in mumps outbreaks prompts U.S. panel to endorse 3rd vaccine doseExpert panel recommends new shingles vaccine that gives increased protectionFDA’s Gottlieb calls for greater use of medication-assisted treatment to fight opioid epidemic (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - October 26, 2017 Category: Consumer Health News Source Type: news

CDC Advisers Recommend New Herpes Zoster Vaccine over Zostavax (FREE)
By Kelly Young Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM The CDC's Advisory Committee on Immunization Practices voted on Wednesday to recommend use of the newly approved herpes zoster vaccine, Shingrix.The inactivated, recombinant subunit, two-dosevaccine … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 26, 2017 Category: Primary Care Source Type: news

CDC Advisers Recommend New Herpes Zoster Vaccine over Zostavax (FREE)
By Kelly Young Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM The CDC's Advisory Committee on Immunization Practices voted on Wednesday to recommend use of the newly approved herpes zoster vaccine, Shingrix.The non-live, recombinant subunit, two-dosevaccine … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 26, 2017 Category: Primary Care Source Type: news

ACIP Narrowly Recommends Shingrix for Shingles Over Zostavax ACIP Narrowly Recommends Shingrix for Shingles Over Zostavax
As a whole, the CDC panel is sold on the new recombinant vaccine to prevent herpes zoster, but some members want more safety data before they endorse it over Zostavax.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 25, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Rise in mumps outbreaks prompts U.S. panel to endorse 3rd vaccine dose
A federal expert panel on Wednesday recommended a third dose of the mumps vaccine when an outbreak occurs. The move was in response to the rise in mumps outbreaks since 2006, especially among highly vaccinated college students. More than 6,000 cases of the contagious viral illness were reported last year in the United States, the most […]Related:Expert panel recommends new shingles vaccine that gives increased protectionFDA’s Gottlieb calls for greater use of medication-assisted treatment to fight opioid epidemicWorld leaders rehearse for a pandemic that will come ‘sooner than we expect’ (Sour...
Source: Washington Post: To Your Health - October 25, 2017 Category: Consumer Health News Source Type: news

CDC recommends new shingles vaccine to replace older one
A new adult vaccine has received a double thumbs-up from the American federal health system. (Source: CNN.com - Health)
Source: CNN.com - Health - October 25, 2017 Category: Consumer Health News Source Type: news

C.D.C. Panel Recommends a New Shingles Vaccine
Shingrix is considered much more effective than the older vaccine, Zostavax. Health officials urged consumers over age 50 to be vaccinated. (Source: NYT Health)
Source: NYT Health - October 25, 2017 Category: Consumer Health News Authors: SHEILA KAPLAN Tags: Shingles (Disease) Vaccination and Immunization Advisory Committee on Immunization Practices Centers for Disease Control and Prevention Source Type: news

Expert panel recommends new shingles vaccine that gives increased protection
A federal expert panel Wednesday recommended a new and more effective shingles vaccine to protect adults 50 and older from a painful rash that affects 1 in 3 people during their lifetime. In a rare move, the Advisory Committee on Immunization Practices also recommended, by an 8-to-7 vote, that the new Shingrix vaccine be preferred over […]Related:FDA’s Gottlieb calls for greater use of medication-assisted treatment to fight opioid epidemicWorld leaders rehearse for a pandemic that will come ‘sooner than we expect’U.S. abortion rate fell 25 percent from 2008 to 2014; one in four women have an a...
Source: Washington Post: To Your Health - October 25, 2017 Category: Consumer Health News Source Type: news

Panel recommends new, better shingles shot over old version
Federal panel recommends anyone vaccinated for shingles get a new, better shot approved last week (Source: ABC News: Health)
Source: ABC News: Health - October 25, 2017 Category: Consumer Health News Tags: Health Source Type: news

U.S. committee recommends GSK shingles vaccine over Merck rival
LONDON (Reuters) - The committee responsible for U.S. vaccination schedules has given a preferential recommendation to GlaxoSmithKline's newly approved shingles vaccine Shingrix over Merck& Co's established product Zostavax. (Source: Reuters: Health)
Source: Reuters: Health - October 25, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Correction: FDA-Shingles Vaccine story
(Source: ABC News: Health)
Source: ABC News: Health - October 25, 2017 Category: Consumer Health News Tags: Health Source Type: news

New Shingles Vaccine Approved by FDA
Title: New Shingles Vaccine Approved by FDACategory: Health NewsCreated: 10/23/2017 12:00:00 AMLast Editorial Review: 10/24/2017 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - October 24, 2017 Category: Dermatology Source Type: news

New Shingles Vaccine, Shingrix, Approved by FDA
A new, more effective shingles vaccine has been approved by the U.S. Food and Drug Administration. The new vaccine from GlaxoSmithKline will be the second shingles vaccine available in the U.S. market. The other is from Merck and was introduced in... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 23, 2017 Category: General Medicine Source Type: news

FDA approves better vaccine against shingles
Studies funded by the vaccine maker found it prevents painful shingles outbreaks in about 90 percent of people (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 23, 2017 Category: Consumer Health News Source Type: news

FDA Clears Shingles Vaccine Shingrix for Adults 50 and Older FDA Clears Shingles Vaccine Shingrix for Adults 50 and Older
The approval follows a unanimous vote last month by an FDA panel that concluded that the vaccine is effective and safe for adults aged 50 years and older.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 23, 2017 Category: Consumer Health News Tags: Infectious Diseases News Alert Source Type: news

FDA Approves New Shingles Vaccine
New vaccine, said to be more effective, is second approved for U.S. market. (Source: WebMD Health)
Source: WebMD Health - October 23, 2017 Category: Consumer Health News Source Type: news

Health Highlights: Oct. 23, 2017
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: New Shingles Vaccine Approved by FDA A new, more effective shingles vaccine has been approved by the U.S. Food and Drug Administration. The... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 23, 2017 Category: General Medicine Source Type: news

GSK wins U.S. shingles vaccine approval, UK nod for gene therapy
LONDON (Reuters) - GlaxoSmithKline has won U.S. approval for a new and improved shingles vaccine, the second of three key products for which the British drugmaker expects approval this year. (Source: Reuters: Health)
Source: Reuters: Health - October 23, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Approves New Herpes Zoster Vaccine (FREE)
By the Editors The FDA has approved a second vaccine to prevent herpes zoster in adults aged 50 and older, the manufacturer announced on Friday. … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 23, 2017 Category: Primary Care Source Type: news

Improved shingles vaccine approved
An improved shingles vaccine has been approved by the U.S. Food and Drug Administration and the?Centers for Disease Control and Prevention's Advisory Committee is expected to vote on the recommendation the week of Monday Oct. 23. The new vaccine, which reportedly prevents shingles in 90 percent of people, is recommended for adults 50 and over. [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 23, 2017 Category: Databases & Libraries Source Type: news

FDA approves better vaccine against painful shingles virus
US regulators approve a new, more effective vaccine to prevent painful shingles caused by the chickenpox virus (Source: ABC News: Health)
Source: ABC News: Health - October 20, 2017 Category: Consumer Health News Tags: Health Source Type: news

GlaxoSmithKline adult shingles vaccine wins U.S. approval
(Reuters) - The U.S. Food and Drug Administration approved GlaxoSmithKline's Shingrix shingles vaccine for use in adults aged 50 and over, a move widely expected after an advisory panel to the agency last month voted unanimously to recommend its approval, the company announced on Friday. (Source: Reuters: Health)
Source: Reuters: Health - October 20, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Shingrix (zoster vaccine recombinant, adjuvanted) Approved in the U.S. for Prevention of Shingles
London UK 20 October 2017 -- GlaxoSmithKline plc [LSE/NYSE: GSK] today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) in adults... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 20, 2017 Category: Drugs & Pharmacology Source Type: news

GSK ’s Shingrix receives approval in Canada to prevent shingles
GlaxoSmithKline ’s (GSK) non-live, recombinant sub-unit, adjuvanted vaccine Shingrix has received approval from Health Canada to prevent shingles (herpes zoster) in people aged 50 or older. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 15, 2017 Category: Pharmaceuticals Source Type: news

GSK Shingles Vaccine Shingrix Gets First Okay in Canada GSK Shingles Vaccine Shingrix Gets First Okay in Canada
Shingrix, given in two doses 2 to 6 months apart, is for adults aged 50 years and older. It was shown to achieve ≥ 90% efficacy in clinical trials.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 13, 2017 Category: Consumer Health News Tags: Infectious Diseases News Alert Source Type: news

GlaxoSmithKline's shingles vaccine gets approval in Canada
(Reuters) - Canadian health regulators have approved GlaxoSmithKline's key shingles vaccine, the company said on Friday. (Source: Reuters: Health)
Source: Reuters: Health - October 13, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Most Physicians Say Shingrix Important Development for Shingles Most Physicians Say Shingrix Important Development for Shingles
Although many primary care providers were unfamiliar with the shingles vaccine, they were impressed with it after they learned about it.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 11, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Shingles Quiz: Symptoms, Vaccine & Pictures
Title: Shingles Quiz: Symptoms, Vaccine& PicturesCategory: MedicineNet QuizCreated: 6/11/2010 12:00:00 AMLast Editorial Review: 9/19/2017 5:50:16 PM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - September 19, 2017 Category: Dermatology Source Type: news

FDA Advisers Recommend Approval of New Shingles Vaccine (FREE)
By the Editors An FDA advisory panel voted 11-0 on Wednesday in favor of approving the Shingrix herpes zoster vaccine for adults … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 14, 2017 Category: Primary Care Source Type: news

US FDA advisory committee votes for GSK ’s Shingrix to prevent shingles
The US Food and Drug Administration ’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) has voted unanimously for GlaxoSmithKline’s (GSK) Shingrix (HZ/su) to prevent herpes zoster (shingles) in adults of 50 years of age and a… (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 13, 2017 Category: Pharmaceuticals Source Type: news

FDA Panel Recommends New Shingles Vaccine FDA Panel Recommends New Shingles Vaccine
An FDA panel unanimously recommended zoster vaccine recombinant (adjuvanted) (Shingrix, GlaxoSmithKline) for adults aged 50 years and older.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 13, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

GSK's shingles vaccine gets positive FDA recommendation
A Food and Drug Administration advisory panel voted unanimously Wednesday to recommend approval for GlaxoSmithKline's new drug candidate Shingrix, a vaccine for preventing shingles in adults age 50 and older. The vote by the Vaccines and Related Biological Products Advisory Committee was 11-0 in support of the biologics license application submitted by GlaxoSmithKline last October. The committee's recommendation is nonbinding, but the FDA typically follows the advice of its advisory panels. If… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 13, 2017 Category: Biotechnology Authors: John George Source Type: news